Ethics approval and consent to participate
DISEASE
The privacy of the patients was protected. A detailed explanation of the disease and treatment was provided. This study was approved by the Ethics Committee of the Shiraz University of Medical Sciences (IR.SUMS.MED.REC.1396.04), and written informed consent was obtained from the subjects. All methods were carried out in accordance with relevant guidelines and regulations.